NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma

Clinical trial NCT07740941 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07740941
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin Cancer)Melanoma Stage Stage IIIB Melanoma Stage M1 Melanoma Stage IV

Start date: 2026-08-05
Primary completion: 2029-03-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.